IL10 and stroke disorder: Furthermore, we observed a trend towards significantly higher IL‐10 and IL‐4 expression at 48 hr, indicating that BML‐111 may be maximally effective at reducing pro‐inflammatory cytokines and increasing anti‐inflammatory cytokines 48 hr after stroke.